Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States

IMPORTANCE. Deaths among patients with coronavirus disease 2019 (COVID-19) are partially attributed to venous thromboembolism and arterial thromboses. Anticoagulants prevent thrombosis formation, possess anti-inflammatory and anti-viral properties, and may be particularly effective for treating pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rentsch, Christopher T, Beckman, Joshua A, Tomlinson, Laurie, Gellad, Walid F, Alcorn, Charles, Kidwai-Khan, Farah, Skanderson, Melissa, Brittain, Evan, King, Joseph T, Ho, Yuk-Lam, Eden, Svetlana, Kundu, Suman, Lann, Michael F, Greevy, Robert A, Ho, P. Michael, Heidenreich, Paul A, Jacobson, Daniel A, Douglas, Ian J, Tate, Janet P, Evans, Stephen JW, Atkins, David, Justice, Amy C, Freiberg, Matthew S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743107/
https://www.ncbi.nlm.nih.gov/pubmed/33330896
http://dx.doi.org/10.1101/2020.12.09.20246579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743107/
https://www.ncbi.nlm.nih.gov/pubmed/33330896
http://dx.doi.org/10.1101/2020.12.09.20246579

Ejemplares similares